Given that colorectal cancer is highly heterogeneous, a particular focus has been made upon the relation of the CB1 immunoreactive intensities with key pathological/molecular components of the disease [23]: stage, tumour grade, microsatellite instability screening status, incidence of buds at the tumour front, and CpG island methylator phenotype (CIMP). Here, CNR1 is linked to neoplasm.